Selected article for: "ANA antinuclear antibody and antinuclear antibody"
Author: Danssaert, Zach; Raum, George; Hemtasilpa, Somkiat
Title: Reactive Arthritis in a 37-Year-Old Female With SARS-CoV2 Infection
  • Cord-id: jpdhtynv
  • Document date: 2020_8_12
    • ID: jpdhtynv
    Snippet: We report the case of a 37-year-old female who presented for evaluation of acute 10/10 right hand pain, 12 days after testing positive for SARS-CoV2. The patient was admitted to the hospital due to the severity of her pain. As an inpatient, extensive workup by the medicine team and rheumatology revealed no structural, vascular, or neurogenic cause of her pain. The patient's blood work was unremarkable for elevations in lyme serology, antinuclear antibody (ANA), rheumatoid factor, and uric acid.
    Document: We report the case of a 37-year-old female who presented for evaluation of acute 10/10 right hand pain, 12 days after testing positive for SARS-CoV2. The patient was admitted to the hospital due to the severity of her pain. As an inpatient, extensive workup by the medicine team and rheumatology revealed no structural, vascular, or neurogenic cause of her pain. The patient's blood work was unremarkable for elevations in lyme serology, antinuclear antibody (ANA), rheumatoid factor, and uric acid. It was determined that the cause of her pain was most likely reactive arthritis (ReA) secondary to her SARS-CoV2 infection. She was treated with voltaren gel, neurontin, and oral dilaudid as needed and discharged. Upon follow-up, her pain improved and she was prescribed a wrist splint, ultram, and occupational therapy for perceived wrist tendinitis. To our knowledge, this is the first description of a case of ReA caused by the SARS-CoV2 virus.

    Search related documents:
    Co phrase search for related documents
    • abnormal immune response and lupus erythematosus: 1
    • acid level and active sars: 1
    • acid level and admission time: 1, 2
    • active sars and acute onset: 1
    • active sars and admission time: 1
    • active sars and lupus erythematosus: 1, 2
    • acute inflammation and admission time: 1, 2, 3
    • acute inflammation and lupus erythematosus: 1, 2
    • acute inflammation and lymphadenopathy rash: 1
    • acute onset and admission time: 1, 2, 3, 4, 5, 6, 7, 8
    • acute onset and lupus erythematosus: 1, 2, 3
    • acute onset and lyme disease: 1, 2